| 高雄醫學大學 |
2014 |
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
|
Fuchs, CS;Tomasek, J;Yong, CJ;Dumitru, F;Passalacqua, R;Goswami, C;Safran, H;dos Santos, LV;Aprile, G;Ferry, DR;Melichar, B;Tehfe, M;Topuzov, E;Zalcberg, JR;Chau, I;Campbell, W;Sivanandan, C;Pikiel, J;Koshiji, M;Hsu, Y;Liepa, AM;Gao, L;Schwartz, JD;Tabernero, J;王照元 ; Fuchs, CS;Tomasek, J;Yong, CJ;Dumitru, F;Passalacqua, R;Goswami, C;Safran, H;dos Santos, LV;Aprile, G;Ferry, DR;Melichar, B;Tehfe, M;Topuzov, E;Zalcberg, JR;Chau, I;Campbell, W;Sivanandan, C;Pikiel, J;Koshiji, M;Hsu, Y;Liepa, AM;Gao, L;Schwartz, JD;Tabernero, J;Wang , Jaw-Yuan |
